The American Society of Laser Medicine & Surgery (ASLMS) will host an East Coast Laser Aesthetics Course on September 20-21, 2014, at the Hyatt Regency in Jersey City, New Jersey.
This course is designed for anyone who desires to have a deeper understanding of how lasers work and then apply that knowledge to accomplish optimum clinical outcomes. It is geared toward individuals who currently use or are investigating the use of lasers and other light-based technology in an array of clinical aesthetic applications.
PhotoMedex, a global skin health company, has entered into a definitive agreement to acquire LCA-Vision for $5.37 per share in cash, or approximately $106.4 million. LCA-Vision Inc. is a provider of laser vision correction services under the LasikPlus brand.
Combination treatment with pulsed dye and Nd:YAG lasers is effective for some basal cell carcinoma (BCC) and may offer better cosmetic outcomes for patients, according to a new study published in Lasers in Surgery and Medicine (January 2014).
For “Combined 585nm Pulsed-Dye and 1,064nm Nd:YAG Lasers for the Treatment of Basal Cell Carcinoma”), Harvard researchers, H. Ray Jalian, MD, et al, studied the outcomes of 10 patients with 13 biopsy-proven BCCs who underwent four combined PDL and Nd:YAG at treatments two to four week intervals.
Valeant Pharmaceuticals has entered into a definitive agreement to acquire all of the outstanding common stock of Solta Medical, a developer and marketer of aesthetic technologies—including Fraxel, Thermage and Liposonix—for $2.92 per share in cash. The transaction is expected to close in the first quarter of 2014.
Jeffrey S. Dover, MD, FRCPC, has taken office as the president of the American Society for Laser Medicine & Surgery (ASLMS). He took office at Laser 2013, the ASLMS annual scientific conference held in Boston, Massachusetts in March. He will serve for one year.
The American Society for Laser Medicine & Surgery is now accepting scientific abstracts for possible presentation at Laser 2013, the 33rd annual meeting of the ASLMS. Abstracts describing the latest research and clinical findings about laser medicine and related technologies must be submitted for consideration online by Monday, October 22, 2012 at www.aslmsabstract.org/.
Fractionated technologies continue to expand and evolve, offering practitioners more targeted options.
The 1550nm Fraxel laser from Reliant Technologies (now Solta Medical, www.solta.com) introduced the medical aesthetics industry to an entirely new category of devices. Featuring a fractionated delivery system that breaks laser beams into tiny dots that create thermal zones of injury surrounded by healthy tissue, the Fraxel—and the many devices it inspired—expanded the patient base for laser skin resurfacing.
Medical laser developer Lumenis has entered into a joint research, development and licensing agreement with the Wellman Center for Photomedicine at Massachusetts General Hospital, an academic research facility dedicated to light-based biomedical research. The goal of the partnership is to develop new treatments that will progress the field by expanding indications and improving patient outcomes.